SUPHA PHARMACHEM LIMITED Share Price

SUPHA PHARMACHEM LIMITED Share Price

BSE: 539561
|
Trading
|
S Cap
₹ 0.28
+₹0.01 (3.70%)
1D
Last updated 07 Sep, 2026, 15:29 IST

SUPHA PHARMACHEM LIMITED Share Price Today

As of 7 Sep 2026, SUPHA PHARMACHEM LIMITED share price is ₹0.28. The stock opened at ₹0.27, compared to its previous close of ₹0.27. During today's trading session, SUPHA PHARMACHEM LIMITED share price moved in the range of ₹0.26 to ₹0.28, with an average price of ₹0.27 for the day. Looking at its last 52-week, the stock has touched a low of ₹0.25 and a high of ₹1.80.

₹0.26
3.70% up today
₹0.28
1D LOW
1D HIGH

SUPHA PHARMACHEM LIMITED Returns Calculator

Circuit
L
H
₹0.26
₹0.28
52-week
L
H
₹0.25
₹1.80

About SUPHA PHARMACHEM LIMITED

SUPHA PHARMACHEM LIMITED Share Price
ISIN
INE549S01036
Sector Market Cap
₹ 73.38 Cr

Supha Pharmachem Limited, formerly Remedium Lifecare Limited, is an India-based pharmaceutical and specialty chemicals company engaged in trading and distribution of raw materials for the pharmaceutical industry. The Company is engaged in the business of trading in advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and other pharma products used viz. Isopropyl Alcohol (IPA) ,Cyclohexane, Diisopropyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Methylene Dichloride, Potassium Carbonate Powder, Sodium Bicarbonate, Potassium Hydroxide Flakes, Sodium Chloride (common salt), Sodium Carbonate (soda ash), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, and Trimethyl Sulfoxonium Iodide (TMSI).

SUPHA PHARMACHEM LIMITED Financial Highlights

  • Revenue: SUPHA PHARMACHEM LIMITED reported revenue of ₹233.30 crore in FY25 vs ₹4,062.79 crore in FY24. It showed a decrease of 94.26% on a yearly basis.
  • Operating Profit: SUPHA PHARMACHEM LIMITED reported an operating profit of ₹3.66 crore in FY25 vs ₹50.45 crore in FY24. It showed a decrease of 92.75% on a year-on-year basis.
  • Net Profit: SUPHA PHARMACHEM LIMITED reported a net profit of ₹1.53 crore in FY25 vs ₹32.73 crore in FY24. It showed a decrease of 95.33% on a yearly basis.

SUPHA PHARMACHEM LIMITED Quarterly Result Highlights

  • SUPHA PHARMACHEM LIMITED reported revenue of ₹114.31 crore in Sep 2025, compared with ₹116.85 crore in Jun 2025, representing a decrease of 2.17% on a quarter-on-quarter (QoQ) basis.
  • SUPHA PHARMACHEM LIMITED reported an operating profit of ₹10.44 crore in Sep 2025, compared with ₹5.71 crore in Jun 2025, representing an increase of 82.84% on a quarter-on-quarter (QoQ) basis.
  • SUPHA PHARMACHEM LIMITED reported a profit of ₹8.62 crore in Sep 2025, compared with ₹4.65 crore in Jun 2025, reflecting an increase of 85.38% on a QoQ basis.
  • The earnings per share (EPS) of SUPHA PHARMACHEM LIMITED stood at ₹0.05 during Sep 2025.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
1.13%
FII
1.70%
Other DII
0.00%
Retail and other
97.17%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20250.00%
Jun 20250.00%
Sep 20250.00%
Dec 20251.70%
Mkt Cap Cr
73.38
P/E
36.40
P/B
1.67
ROE
4.85%
D/E
11.97
ROCE
1.01%
Div. Yield
0.00%
EPS(TTM)
0.04
Turnover
0.10
EV/EBITDA
100.58
Net Margin
0.69%
Op. Margin
5.10%
ROA
0.18%
Quick Ratio
0.85
Curr. Ratio
4.32
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Remedium Life has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Remedium Life appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Remedium Life earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,55,634.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,41,576.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Cipla1,11,888.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Zydus Lifesciences1,11,820.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin96,528.8017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Dr. Reddy's Laboratories96,322.1030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,127.2025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SUPHA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025
Revenue₹405.25
Other Income₹10.80
Total Revenue₹416.05
Total Expenses₹411.67
Profit Before Tax₹4.38
Tax₹2.26
Profit After Tax₹2.13
EPS - Basic₹0.05
EPS - Diluted₹0.05

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025
Profit before tax₹4.38
Income before WC changes₹9.58
Change in Assets-₹1,679.45
Change in Liabilities₹535.06
Change in WC-₹1,144.39
Cash flow from Operations-₹1,134.81
Cash flow from Investing₹0.13
Cash flow from Financing₹1,136.10
Total Cash Flow₹1.43
Cash (Start of the year)₹0.00
Cash (End of the year)₹1.43

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025
Non-Current Assets₹0.04
Current Assets₹1,720.30
Total Assets₹1,720.35
Current Liabilities₹1,676.46
Net Current Asset₹43.85
Non-Current Liabilities₹0.00
Equity Capital₹43.89
Total Equity & Liabilities₹1,720.35

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹222.50₹4,041.71₹509.84₹504.79
Other Income₹10.80₹21.08₹0.00₹0.00
Total Revenue₹233.30₹4,062.79₹509.84₹504.79
Total Expenses₹229.64₹4,012.33₹502.44₹503.27
Profit Before Tax₹3.66₹50.45₹7.40₹1.53
Tax₹2.13₹17.72₹1.97₹0.45
Profit After Tax₹1.53₹32.73₹5.43₹1.08
EPS - Basic₹0.04₹3.25₹15.07₹2.99
EPS - Diluted₹0.04₹3.25₹15.07₹2.99

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹3.66₹50.45₹7.40₹1.53
Income before WC changes₹8.86₹54.29₹7.58₹1.71
Change in Assets₹405.30-₹813.04-₹910.15-₹184.62
Change in Liabilities-₹1,492.30₹702.40₹925.04₹194.65
Change in WC-₹1,087.00-₹110.64₹14.89₹10.03
Cash flow from Operations-₹1,078.63-₹74.16₹20.50₹11.28
Cash flow from Investing₹0.06₹0.00-₹0.04-₹0.05
Cash flow from Financing₹1,078.40₹53.83-₹0.04-₹10.61
Total Cash Flow-₹0.16-₹20.33₹20.42₹0.62
Cash (Start of the year)₹1.52₹21.86₹1.44₹0.81
Cash (End of the year)₹1.36₹1.52₹21.86₹1.44

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.11₹0.07₹0.09₹0.19
Current Assets₹1,539.54₹1,947.85₹1,154.14₹223.57
Total Assets₹1,539.65₹1,947.92₹1,154.22₹223.76
Current Liabilities₹1,496.35₹1,904.97₹1,143.86₹218.82
Net Current Asset₹43.19₹42.88₹10.28₹4.75
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹43.30₹42.96₹10.36₹4.94
Total Equity & Liabilities₹1,539.65₹1,947.92₹1,154.22₹223.76
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0.28
1004209
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1004209
Buy orders: 0%
Sell orders: 100%
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
32.43
Neutral
ATR (14)
0.01
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
42.77
Bearish
UO(9)
43.61
Neutral
ROC(12)
-12.9
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
0.28
0.28
10D
0.29
0.29
20D
0.3
0.3
50D
0.31
0.32
100D
0.34
0.38
Volume trend — traded volume by day
7 Sep24L
4 Sep31L
3 Sep19L
2 Sep8L
1 Sep15L
31 Aug14L
Average19L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
SUPHA PHARMACHEM LIMITED Share Price
SUPHA PHARMACHEM LIMITED
Trading
Add Stock
Add Another

SUPHA PHARMACHEM LIMITED Share Price FAQs

SUPHA PHARMACHEM LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837